Publications
155
Citations
8,530
Est. group size
~10
Recurring co-author estimate
Active years
29
Publishing since 1996
This researcher studies how the immune system can be harnessed to fight cancer, including how immune cells recognize and respond to tumors, how antibodies and cell-surface receptors regulate immune activity, and how new drug compounds or engineered nanomaterials can boost anti-tumor immune responses. Work spans blood cancers (leukemia, myeloma) and solid tumors (pancreatic cancer, brain tumors), often combining immunology with cancer therapeutics and drug or nanoparticle development.
Publication output has fluctuated over the last decade with a peak in 2019, a dip during 2020–2021, and a partial rebound in 2022–2023, averaging about 2 papers per year over the most recent five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer
Cells · 2023
- The Potent Dihydroorotate Dehydrogenase Inhibitor, Hosu-53, Exhibits Compelling Monotherapy Efficacy in Multiple Myeloma and Augments CD47 Targeted Therapy
Blood · 2023
- RBIO-01. ACTIVATING AN ION CHANNEL PROMOTES RADIATION-SENSITIZING IMMUNE-DRIVEN ANTI-TUMOR ACTIVITY
Neuro-Oncology · 2022
- Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor Accentuates CD47 Blockade Therapy Resulting in Long Term Survival in Acute Myeloid Leukemia
Blood · 2022
- Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
ACS Applied Nano Materials · 2021
- CD31 acts as a checkpoint molecule and is modulated by FcγR-mediated signaling in monocytes
The Journal of Immunology · 2019
- Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy
Nanomedicine Nanotechnology Biology and Medicine · 2016
- A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas
Cancer Immunology Immunotherapy · 2016
- The Journal of Immunology×5
- Cancer Research×4
- Clinical Cancer Research×3
- Scientific Reports×2
- Cancer Immunology Research×2
- Jonathan P. Butchar
Medicine · The Ohio State University
- William P. Lafuse
Medicine · The Ohio State University
- Samuel D. Stimple
Medicine · The Ohio State University
- L.D. Ward
Medicine · Indiana University
- John W. Schrader
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile